Pure Global AI
Manufacturer profile

FUJIREBIO INC. SAGAMIHARA FACILITY.

TaiwanJapan5 products registeredAug 14, 2014 – Jul 14, 2020
VerifiedTFDA · Taiwan Food and Drug Administration registry
5
Total products
5
Product types
5
Active products
Jul 2020
Latest registration
Company details
Address
1-3-14, TANASHIODA, CHUO-KU, SAGAMIHARA-SHI, KANAGAWA, 252-0245 JAPAN.
Regulatory footprint
Search FUJIREBIO INC. SAGAMIHARA FACILITY. across other regulatory registries
ThailandEuropean UnionColombiaSouth KoreaCanadaEcuador
Recent registrations
Latest 5 products registered by this manufacturer
Lumipulse G Myoglobin
Class 2
Jul 14, 2020
Recording of Paz G high-sensitivity cardiac troponin-I assay
Class 2
Jul 01, 2019
Lumipulse G CK-MB
Class 2
Dec 12, 2018
Lumipulse G HBsAg-Quant
Class 3
Aug 07, 2018
Recording of prothrombin pars and salivary liquefied glycochain antigen controls
Class 2
Aug 14, 2014
Most popular products
Products with most registrations
Lumipulse G Myoglobin
1 registrations
Recording of Paz G high-sensitivity cardiac troponin-I assay
1 registrations
Lumipulse G CK-MB
1 registrations
Lumipulse G HBsAg-Quant
1 registrations
Recording of prothrombin pars and salivary liquefied glycochain antigen controls
1 registrations
Authorized representatives
Taiwan authorized representatives for this manufacturer
Grand Marquis IVD CO., LTD.
5 products
Recent registered products
Most recent products (showing top 20)
Lumipulse G Myoglobin
Registered: Jul 14, 2020 • Expires: Jul 14, 2025
Risk Class
Class 2
Type
MD
AR
Grand Marquis IVD CO., LTD.
Recording of Paz G high-sensitivity cardiac troponin-I assay
Registered: Jul 01, 2019 • Expires: Jul 01, 2029
Risk Class
Class 2
AR
Grand Marquis IVD CO., LTD.
Lumipulse G CK-MB
Registered: Dec 12, 2018 • Expires: Dec 12, 2023
Risk Class
Class 2
Type
MD
AR
Grand Marquis IVD CO., LTD.
Lumipulse G HBsAg-Quant
Registered: Aug 07, 2018 • Expires: Aug 07, 2028
Risk Class
Class 3
Type
MD
AR
Grand Marquis IVD CO., LTD.
Recording of prothrombin pars and salivary liquefied glycochain antigen controls
Registered: Aug 14, 2014 • Expires: Aug 14, 2029
Risk Class
Class 2
AR
Grand Marquis IVD CO., LTD.
About this profile

Explore comprehensive manufacturer profile for FUJIREBIO INC. SAGAMIHARA FACILITY. based in Japan through Pure Global AI's free Taiwan medical device database. This manufacturer has 5 products registered in Taiwan across 5 unique product categories. Their regulatory history spans from Aug 14, 2014 to Jul 14, 2020.

This page provides detailed insights including 5 recent product registrations, 5 most popular products with Lumipulse G Myoglobin having 1 registrations, and 1 authorized representatives including Grand Marquis IVD CO., LTD.. Pure Global AI offers free access to Taiwan's medical device database, enabling global MedTech companies to analyze market dynamics and identify opportunities.